Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01791179 · ClinicalTrials.gov registry record · NA

Carolina Alcohol and Drug Resources

A NA study of HIV, sponsored by Duke University.

Completed
Registry status
NA
Development phase
306
Enrollment target
1
Study location

NCT01791179 is a NA study of HIV that has completed, run by Duke University. The registered enrollment target is 306 participants, below the 439-participant average among 303 other HIV trials with a reported enrollment target (30% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01791179, a NA study of HIV, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
306 participants
Enrollment target
1
Study location

Study Summary

Substance abuse is highly prevalent among individuals with HIV and associated with negative outcomes including poorer medication adherence and HIV risk behavior. The primary aim of this project is to address substance abuse among individuals with or at high-risk for HIV by enhancing and expanding the substance abuse services provided in the formerly Substance Abuse and Mental Health Services Administration (SAMHSA) funded Carolinas Alcohol and Drug Expansion Team (CADET) program, which offered comprehensive substance abuse care for individuals with HIV living primarily in the Durham NC area. Services will be enhanced by adding peer outreach and navigation services to improve treatment engagement and participation and expanded to replicate the enhanced CADET service model in Charlotte NC. The target population for this project is minority individuals, primarily African-Americans, with HIV or at high-risk for HIV with a particular focus on minority men who have sex with men (MSM)s. The program will provide up to 18 months of comprehensive services for approximately 315 individuals and will include: 1) peer outreach to facilitate and enhance treatment engagement 2) individual and group substance abuse treatment using evidence-based models 3) ongoing recovery groups for individuals who have completed the intensive substance abuse treatment phase and 4) linkage to needed services such as case management, psychiatric care, and HIV/Hepatitis medical care. We will also target HIV and Hepatitis C testing and treatment services for minority MSM of unknown HIV status to increase access and utilization of substance use services and identify HIV and Hepatitis status. The study evaluation will involve analysis of participant survey data gathered at baseline, 6, 12, 18 months of study participation to determine the effect of the comprehensive substance abuse care services on outcomes for individuals with HIV including substance use, mental health, HIV treatment adherence, HIV ri

Conditions Studied

Interventions

  • BEHAVIORAL Comprehensive substance abuse services

Study Locations (1)

North Carolina

  • Duke University - Durham

Trial Details

FieldValue
Enrollment Target 306 participants
Start Date 2013-02
Est. Completion 2018-01-31
Phase NA

Sponsor

Duke University

1,725 total trials

What the Registry Record Tells You About NCT01791179

The ClinicalTrials.gov registry entry for NCT01791179 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 306 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 439-participant average among 303 other HIV trials with a reported enrollment target (30% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV appearing as the primary indexed condition, and to 1 intervention - of which Comprehensive substance abuse services is the first listed.

NCT01791179 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT01791179 about?

NCT01791179 is a clinical study titled "Carolina Alcohol and Drug Resources". Substance abuse is highly prevalent among individuals with HIV and associated with negative outcomes including poorer medication adherence and HIV risk behavior. The primary aim of this project is to address substance abuse among individuals with or at high-risk for HIV by enhancing and expanding th...

What is the current status of trial NCT01791179?

This trial is currently completed. It is a NA study. The enrollment target is 306 participants. The study started on 2013-02. Estimated completion is 2018-01-31.

What conditions does trial NCT01791179 study?

This clinical trial studies the following conditions: HIV.

What interventions are being tested in trial NCT01791179?

The interventions under investigation include: Comprehensive substance abuse services (BEHAVIORAL).

Who is sponsoring clinical trial NCT01791179?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01791179 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.